-
Founded in:
2011-09-06 -
Country:
China -
Address:
No. 2, Jinfengyuan Road, Science City, Huangpu District, Guangzhou (the fourth building) -
Tax NO.:
91441600581445197U -
Registered Funds:
70 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Piracetam |
This product is a brain metabolism improving drug, which is a cyclic derivative of g-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote ATP in the brain, promote acetylcholine synthesis and positively enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.
More
This product is a brain metabolism improving drug, which is a cyclic derivative of g-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote ATP in the brain, promote acetylcholine synthesis and positively enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability. |
7491-74-9 | 24 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pipemidic acid |
This product is a quinolone antibacterial drug that acts on bacterial DNA gyrase to interfere with bacterial DNA synthesis, thereby causing bacterial death. It has antibacterial effects on Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Serratia, Salmonella typhi, Shigella, Pseudomonas aeruginosa, etc.
More
This product is a quinolone antibacterial drug that acts on bacterial DNA gyrase to interfere with bacterial DNA synthesis, thereby causing bacterial death. It has antibacterial effects on Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Serratia, Salmonella typhi, Shigella, Pseudomonas aeruginosa, etc. |
51940-44-4 | 3 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pyrithioxin dihydrochloride |
This product is a brain metabolism improving drug, a derivative of vitamin B6, which can promote glucose and amino acid metabolism in the brain, improve systemic assimilation, increase carotid blood flow, and enhance brain function. It also has a certain effect on the limbic system and reticular structure.
More
This product is a brain metabolism improving drug, a derivative of vitamin B6, which can promote glucose and amino acid metabolism in the brain, improve systemic assimilation, increase carotid blood flow, and enhance brain function. It also has a certain effect on the limbic system and reticular structure. |
10049-83-9 | 5 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulpiride |
This product belongs to the benzamide antipsychotic drug, and its characteristic is to selectively block the dopamine (DA2) receptors of the midbrain limbic system, with little effect on other neurotransmitter receptors, mild anticholinergic effect, and no obvious sedative and anti-excitement and agitation effects. This product also has strong antiemetic and gastric secretion inhibition effects
More
This product belongs to the benzamide antipsychotic drug, and its characteristic is to selectively block the dopamine (DA2) receptors of the midbrain limbic system, with little effect on other neurotransmitter receptors, mild anticholinergic effect, and no obvious sedative and anti-excitement and agitation effects. This product also has strong antiemetic and gastric secretion inhibition effects |
15676-16-1 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| TOLBUTAMIDE |
1. Stimulate the pancreatic islet beta cells to secrete insulin, which is a prerequisite for the islet beta cells to also have a certain ability to synthesize and secrete insulin; 2. Inhibit liver glycogenolysis and gluconeogenesis by increasing portal vein insulin levels or directly acting on the liver, and reduce liver glucose production and output; 3. It may also increase the sensitivity of extra-pancreatic tissues to insulin and the utilization of sugar (probably mainly through post-receptor effects). Therefore, the overall effect is to lower fasting blood sugar and postprandial blood sugar.
More
1. Stimulate the pancreatic islet beta cells to secrete insulin, which is a prerequisite for the islet beta cells to also have a certain ability to synthesize and secrete insulin; 2. Inhibit liver glycogenolysis and gluconeogenesis by increasing portal vein insulin levels or directly acting on the liver, and reduce liver glucose production and output; 3. It may also increase the sensitivity of extra-pancreatic tissues to insulin and the utilization of sugar (probably mainly through post-receptor effects). Therefore, the overall effect is to lower fasting blood sugar and postprandial blood sugar. |
64-77-7 | 16 |